Daily Stocks List: Forestar Group Inc. (NYSE:FOR), Ford Motor Company (NYSE:F), Healthways Inc. (NASDAQ:HWAY), Enanta Pharmaceuticals (NASDAQ:ENTA), Codexis (NASDAQ:CDXS)


Forestar Group Inc. (NYSE:FOR) said that, it will release its results for second quarter 2015 on August 5, before the market opens. On 24 July, Forestar Group Inc. (NYSE:FOR) shares moved down -0.15% and was closed at $13.00. FOR EPS growth in last 5 year was -28.30%. Forestar Group Inc. (NYSE:FOR) year to date (YTD) performance is -15.58%.

On 21 July, Ford Motor Company (NYSE:F) introduces its most advanced and luxurious truck ever – the Ford F-150 Limited. Ford Motor Company (NYSE:F) shares moved down -1.51% in last trading session and ended the day at $14.39. F Gross Margin is 12.80% and its has a return on assets of 1.50%. Ford Motor Company (NYSE:F) quarterly performance is -7.89%.

Healthways Inc. (NASDAQ:HWAY) announced financial results for the second quarter and six months ended June 30, 2015. adjusted net income per diluted share of $0.11 compared with $0.01 for the second quarter last year, which excludes non-cash interest expense for the second quarter of each year and expenses associated with the Company’s previously announced CEO transition in the second quarter of 2015.Healthways Inc. (NASDAQ:HWAY) caters to the Healthcare space. It has a net profit margin of -1.10% and weekly performance is 6.69%. On the last day of trading company shares ended up $13.40. Healthways Inc. (NASDAQ:HWAY) distance from 50-day simple moving average (SMA50) is -5.01%.

On 24 July, Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) announced that the U.S. Food and Drug Administration (FDA) approved AbbVie’s TECHNIVIE™ (ombitasvir, paritaprevir and ritonavir) tablets in combination with ribavirin (RBV) for the treatment of non-cirrhotic adults with genotype 4 (GT4) chronic hepatitis C virus (HCV) infection. TECHNIVIE is the first and only all-oral, interferon-free, direct-acting antiviral treatment approved in the U.S. for adult patients with GT4 chronic HCV infection. Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) shares fell -8.96% in last trading session and ended the day at $45.19. ENTA has a return on assets of 59.70%. Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) quarterly performance is 21.67%.

Zacks lowered shares of Codexis, Inc. (NASDAQ:CDXS) from a hold rating to a sell rating in a report released on Tuesday. Codexis, Inc. (NASDAQ:CDXS) caters to the Healthcare space. It has a net profit margin of -52.60% and weekly performance is -11.46%. On the last day of trading company shares ended up $3.71. Codexis, Inc. (NASDAQ:CDXS) distance from 50-day simple moving average (SMA50) is -9.28%.


Leave a Reply

Your email address will not be published. Required fields are marked *